Original paper
In vitro and in vivo evaluation of anisomycin against Ehrlich ascites carcinoma
Abstract
Anisomycin eminently inhibits cell proliferation in vitro. The aim of this study was to explore the potential of anisomycin to treat tumors in vivo and its mechanism(s) of action. The results showed that peritumoral administration of anisomycin significantly suppressed Ehrlich ascites carcinoma (EAC) growth resulting in the survival of approximately 60% of the mice 90 days after EAC inoculation. Enhancement of infiltrating lymphocytes was noted...
Paper Details
Title
In vitro and in vivo evaluation of anisomycin against Ehrlich ascites carcinoma
Published Date
Mar 21, 2013
Journal
Volume
29
Issue
6
Pages
2227 - 2236
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History